Efficacy and safety of Secukinumab in the treatment of patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
Latest Information Update: 03 Feb 2020
At a glance
- Drugs Secukinumab (Primary)
- Indications Acne; Acquired hyperostosis syndrome; Hyperostosis; Osteitis; Pustulosis; Synovitis
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2020 New trial record